Literature DB >> 11159628

Revised guideline for prescribing vigabatrin in children. Guideline's claim about infantile spasms is not based on appropriate evidence.

A L Lux, S W Edwards, J P Osborne, E Hancock, A L Johnson, C R Kennedy, F J O'Callaghan, R W Newton, C M Verity.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11159628      PMCID： PMC1119485     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Guideline for prescribing vigabatrin in children has been revised. Vigabatrin Paediatric Advisory Group.

Authors: 
Journal:  BMJ       Date:  2000-05-20

2.  Guideline may help in prescribing vigabatrin.

Authors:  R E Appleton
Journal:  BMJ       Date:  1998-11-07

3.  Infantile spasms and vigabatrin. Study will compare effects of drugs.

Authors:  J P Osborne; S W Edwards; E Hancock; A L Lux; F O'Callaghan; T Johnson; C R Kennedy; R W Newton; C M Verity
Journal:  BMJ       Date:  1999-01-02

4.  Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study.

Authors:  F Vigevano; M R Cilio
Journal:  Epilepsia       Date:  1997-12       Impact factor: 5.864

5.  Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms.

Authors:  R E Appleton; A C Peters; J P Mumford; D E Shaw
Journal:  Epilepsia       Date:  1999-11       Impact factor: 5.864

6.  Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis.

Authors:  C Chiron; C Dumas; I Jambaqué; J Mumford; O Dulac
Journal:  Epilepsy Res       Date:  1997-01       Impact factor: 3.045

Review 7.  Vigabatrin as a first-choice drug in the treatment of West syndrome.

Authors:  N Fejerman; R Cersósimo; R Caraballo; J Grippo; S Corral; R H Martino; G Martino; M Aldao; P Caccia; M Retamero; M C Macat; M A Di Blasi; J Adi
Journal:  J Child Neurol       Date:  2000-03       Impact factor: 1.987

8.  ACTH therapy in infantile spasms: side effects.

Authors:  R Riikonen; M Donner
Journal:  Arch Dis Child       Date:  1980-09       Impact factor: 3.791

9.  Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups.

Authors:  J Aicardi; J P Mumford; C Dumas; S Wood
Journal:  Epilepsia       Date:  1996-07       Impact factor: 5.864
  9 in total
  4 in total

1.  Sifting the evidence. Likelihood ratios are alternatives to P values.

Authors:  T V Perneger
Journal:  BMJ       Date:  2001-05-12

Review 2.  A risk-benefit assessment of treatments for infantile spasms.

Authors:  R Nabbout
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 3.  Vigabatrin.

Authors:  James W Wheless; R Eugene Ramsay; Stephen D Collins
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

Review 4.  Selection criteria for the clinical use of the newer antiepileptic drugs.

Authors:  Charles L P Deckers; P D Knoester; G J de Haan; A Keyser; W O Renier; Y A Hekster
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.